Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature

Eur J Cancer. 2017 Sep:83:99-102. doi: 10.1016/j.ejca.2017.06.022. Epub 2017 Jul 19.

Authors

Teresa Deinlein¹, Sigurd F Lax², Thomas Schwarz³, Roberta Giuffrida¹, Karin Schmid-Zalaudek⁴, Iris Zalaudek⁵

Affiliations

¹ Department of Dermatology, Medical University of Graz, Graz, Austria.
² Department of Pathology, Hospital Graz South-West, Graz, Austria.
³ Department of Radiology, Medical University of Graz, Graz, Austria.
⁴ Department of Physiology, Medical University of Graz, Graz, Austria.
⁵ Department of Dermatology, Medical University of Graz, Graz, Austria. Electronic address: iris.zalaudek@gmail.com.

PMID: 28734147
DOI: 10.1016/j.ejca.2017.06.022

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Carcinoma, Squamous Cell / drug therapy*
Carcinoma, Squamous Cell / pathology
Female
Humans
Middle Aged
Neoplasm Metastasis
Remission Induction
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Time Factors
Xeroderma Pigmentosum / drug therapy*
Xeroderma Pigmentosum / pathology

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab